SBS 8th Annual Conference and Exhibition

Venue: NV Netherlands Congress Centre

Location: The Hague, Netherlands

Event Date/Time: Sep 22, 2002 End Date/Time: Sep 26, 2002
Report as Spam


Plans are in full swing for the Society for Biomolecular Screening's 8th Annual Conference and Exhibition scheduled for September 22-26 in The Hague, the Netherlands. Internationally recognized keynote speakers, a renowned peer-reviewed educational program, and at least 150 exhibitors will highlight the Conference attended by more than 3,000 top drug discovery professionals.

Dr. Josef Penninger, acclaimed researcher from the Amgen Institute and the University of Toronto's Immunology Department, will present a keynote address. Penninger is well known for his pioneering research on cell signaling and its importance in autoimmune responses affecting heart disease and osteoporosis. He was recently chosen to head up the newly formed Institute of Molecular and Cellular Bioinformatics in Austria.

NASA scientist and former astronaut Dr. Lawrence DeLucas will present his ongoing protein crystallography research. DeLucas directs the Center for Biophysical Sciences and Engineering at the University of Alabama at Birmingham. DeLucas serves on NASA's Space Station Science Utilization and Advisory Subcommittee, and the U. S. Space and Rocket Center Advisory Committee. He is the recipient of a NASA Research Award for hardware that he designed for protein crystal growth experiments in space.

SBS's 2002 Award Lecture Series, a highlight of the final day of the Conference, will feature Achievement Award winners John Sulston, of the Sanger Centre, and Manfred Auer, of Novartis Drug Discovery Center. Tina Garyantes, of Aventis Pharmaceuticals, Inc., will present the PerkinElmer Award lecture.

The Conference will also feature more than 66 speakers in 12 sessions with topics ranging from novel screening methods to machine intelligence in informatics to trends in automation, miniaturization & nanotechnology.

Point/Counterpoint sessions will look at the pros and cons of virtual screening versus wet screening and the controversial topic of whether natural products have a place in drug discovery.

For more information about the 2002 Conference, visit


The Society for Biomolecular Screening (SBS) provides a forum for education and information exchange amongst professionals within drug discovery and related disciplines-it is committed to the highest standard of professional ethics. Founded in 1994, the Society sponsors an annual international conference, publishes the Journal of Biomolecular Screening, and offers additional benefits for its more than 2,000 members.


Churchillplein 10
The Hague